Literature DB >> 28902952

Successful Treatment of Severe Recalcitrant Hidradenitis Suppurativa with the Interleukin-17A Antibody Secukinumab.

Anna Schuch1, Tatjana Fischer, Alexander Boehner, Tilo Biedermann, Thomas Volz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 28902952     DOI： 10.2340/00015555-2794

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   4.437


× No keyword cloud information.
  10 in total

Review 1.  [Drug therapy of acne inversa].

Authors:  S Schneider-Burrus; E Arpa; C Kors; T Stavermann; R Sabat; G Kokolakis
Journal:  Hautarzt       Date:  2018-01       Impact factor: 0.751

Review 2.  Medical and Surgical Management of Hidradenitis Suppurativa: A Review of International Treatment Guidelines and Implementation in General Dermatology Practice.

Authors:  Lauren A V Orenstein; Tien V Nguyen; Giovanni Damiani; Christopher Sayed; Gregor B E Jemec; Iltefat Hamzavi
Journal:  Dermatology       Date:  2020-05-14       Impact factor: 5.366

3.  Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa: A Phase 2, Double-blind, Placebo-Controlled Randomized Clinical Trial.

Authors:  Sophie Glatt; Gregor B E Jemec; Seth Forman; Christopher Sayed; George Schmieder; Jamie Weisman; Robert Rolleri; Seth Seegobin; Dominique Baeten; Lucian Ionescu; Christos C Zouboulis; Stevan Shaw
Journal:  JAMA Dermatol       Date:  2021-11-01       Impact factor: 10.282

4.  Therapeutic Response to Secukinumab in a 36-Year-Old Woman with Hidradenitis Suppurativa.

Authors:  Astrid-Helene Ravn Jørgensen; Yiqiu Yao; Simon Francis Thomsen
Journal:  Case Rep Dermatol Med       Date:  2018-04-16

5.  Secukinumab and hidradenitis suppurativa: Friends or foes?

Authors:  Claudio Marasca; Matteo Megna; Anna Balato; Nicola Balato; Maddalena Napolitano; Gabriella Fabbrocini
Journal:  JAAD Case Rep       Date:  2019-01-30

Review 6.  Systematic review of immunomodulatory therapies for hidradenitis suppurativa.

Authors:  Shi Yu Derek Lim; Hazel H Oon
Journal:  Biologics       Date:  2019-05-13

Review 7.  Learning From Success and Failure: Biologics for Non-approved Skin Diseases.

Authors:  Reinhart Speeckaert; Jo Lambert; Nanja van Geel
Journal:  Front Immunol       Date:  2019-08-08       Impact factor: 7.561

8.  The anti-inflammatory potency of biologics targeting tumour necrosis factor-α, interleukin (IL)-17A, IL-12/23 and CD20 in hidradenitis suppurativa: an ex vivo study.

Authors:  A R J V Vossen; C B Ardon; H H van der Zee; E Lubberts; E P Prens
Journal:  Br J Dermatol       Date:  2019-04-12       Impact factor: 9.302

9.  Cytokine Pathways and Investigational Target Therapies in Hidradenitis Suppurativa.

Authors:  Ester Del Duca; Paola Morelli; Luigi Bennardo; Cosimo Di Raimondo; Steven Paul Nisticò
Journal:  Int J Mol Sci       Date:  2020-11-10       Impact factor: 5.923

Review 10.  Hidradenitis Suppurativa: Current Understanding of Pathogenic Mechanisms and Suggestion for Treatment Algorithm.

Authors:  S Morteza Seyed Jafari; Robert E Hunger; Christoph Schlapbach
Journal:  Front Med (Lausanne)       Date:  2020-03-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.